Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity

Cell Oncol (Dordr). 2023 Dec;46(6):1871-1872. doi: 10.1007/s13402-023-00890-x.
No abstract available

Publication types

  • Published Erratum